Learn More
The US roadways and bridge decks require an estimated $2.2T in investments to improve from its current <i>D</i> score in the most recent ASCE report card [29] to a good level. A network-wide health assessment of the roadway infrastructure is necessary to direct investments to the areas of most need and benefit. However, current survey methods are too(More)
We report on the chemotherapy plus granulocyte colony-stimulating factor (G-CSF) induced mobilization of peripheral blood progenitor cells (PBPCs) and their impact on haematopoietic recovery following high-dose chemotherapy. Twenty-four patients with advanced solid tumours or lymphomas received standard-dose chemotherapy with VP16, ifosfamide and cisplatin(More)
Ground-penetrating imaging radar (" GPiR ") is a new technology that combines standard GPR (Ground-Penetrating Radar) with accurate positioning and advanced signal processing to create three­ dimensional (3D) images of the shallow subsurface. These images can reveal soil conditions and buried infrastructure—such as utility lines and conduits—down to depths(More)
Understanding the future transportation infrastructure performance demands a smart Cyber-Physical Systems (CPS) approach integrating heterogeneous sensors, versatile computing systems, and mobile agents. However, due to sensor versatility and computing intricacy, designing such systems faces challenges of immense complexity in mobile sensor fusion, big data(More)
Heterogeneous roaming sensor systems have gained significant importance in many domains of civil infrastructure performance inspection as they accelerate data collection and analysis. However, designing such systems is challenging due to the immense complexity in the heterogeneity and processing demands of the involved sensors. Unifying frameworks are(More)
We have measured the levels of interferon gamma (IFN gamma), tumor necrosis factor alpha (TNF alpha), interleukin-1 alpha (IL-1 alpha), IL-1 beta, and IL-2 in the whole blood cell culture supernatants of 43 tumor patients undergoing a treatment with biological response modifiers or a conventional therapy with 5-fluorouracil and leucovorin. In the blood cell(More)
  • 1